sonrotoclax (BGB-11417)

News alerts, weekly reports and conference planners

Company:

BeiGene

Drug class:

Bcl2 inhibitor

Related drugs:

‹

›

Chr t(11;14)	Multiple Myeloma	Chr t(11;14)	Multiple Myeloma	BGB-11417 Sensitive: C3 – Early Trials BGB-11417 Sensitive : C3	BGB-11417 Sensitive: C3 – Early Trials BGB-11417 Sensitive : C3
BCL2 G101V	Chronic Lymphocytic Leukemia	BCL2 G101V	Chronic Lymphocytic Leukemia	BGB-11417 Sensitive: D – Preclinical BGB-11417 Sensitive : D	BGB-11417 Sensitive: D – Preclinical BGB-11417 Sensitive : D

Associations
(2)